Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $79.43 USD
Change Today +1.02 / 1.30%
Volume 399.9K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David M. Stack

Chairman, Chief Executive Officer and President, Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 39 board members in 5 different organizations across 13 different industries.

See Board Relationships
64$7,410,238
As of Fiscal Year 2014

Background*

Mr. David M. Stack, also known as Dave, serves as the Managing Director of MPM Capital. Mr. Stack joined MPM in 2004. Mr. Stack has been the Chief Executive Officer and President of Pacira Pharmaceuticals Inc. since November 2007 and serves as its Chairman of the Board. He leads the transformation of Pacira from a sustained-release injectable technology company into a fully integrated, acute care pharmaceutical company. He is Founder of Stack Pharmaceuticals, Inc and ...

Read Full Background

Corporate Headquarters*

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships*

Chairman
Senior Consultant
2000-2010
Former Independent Director and Member of Audit Committee
2001-N/A
Former Chief Executive Officer, President and Director
2002-N/A
Former Director
2006-N/A
Former Director, Chairman of Compensation Committee and Member of Audit Committee
2007-Present
Chairman, Chief Executive Officer and President
2007-N/A
Former Director
2012-Present
Independent Director and Member of Remuneration Committee
2012-Present
Director and Member of Advisory Board
2015-Present
Chairman

Education*

BS
Siena College
BS
Albany College of Pharmacy and Health Sciences

Other Affiliations*

Annual Compensation*

Salary$596,540
Bonus$425,000
Total Annual Compensation$1,021,540

Stock Options*

All Other Compensation$2,772
Exercised Options55,000
Exercised Options Value$4,553,541
Exercisable Options703,878
Exercisable Options Value$58,645,167
Unexercisable Options281,243
Unexercisable Options Value$11,366,268
Total Value of Options$74,564,975
Total Number of Options1,040,121

Total Compensation*

Total Annual Cash Compensation$1,024,312
Total Short Term Compensation$1,021,540
Other Long Term Compensation$2,772
Total Calculated Compensation$7,410,238
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $79.43 USD +1.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$650.0K
Robert E. Abernathy Chairman, Chief Executive Officer, President and Member of Executive Committee
Halyard Health, Inc.
$787.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.